APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharma Contract Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharma Contract Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026196 pages

Choose your research edition.

Industry ResearchPharma Contract Service Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharma Contract Service Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Pharma Contract Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharma Contract Service Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharma Contract Service Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pharma Contract Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pharma Contract Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharma Contract Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharma Contract Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharma Contract Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharma Contract Service include ICON PLC, IQVIA, PPD, Eurofins Scientific, WuXi AppTec, Labcorp Drug Development, Syneos Health, Parexel and Medpace, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pharma Contract Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharma Contract Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharma Contract Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pharma Contract Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharma Contract Service Segment by Company

ICON PLC

IQVIA

PPD

Eurofins Scientific

WuXi AppTec

Labcorp Drug Development

Syneos Health

Parexel

Medpace

Charles River

Lonza

Aldevron

Catalent

Pharma Contract Service Segment by Type

Contract Research Organization (CRO)

Contract Development and Manufacruring Organization (CDMO)

Contract Manufacturing Organization (CMO)

Pharma Contract Service Segment by Application

Pharmaceutical Company

Biotechnology Company

Generic Company

Pharma Contract Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Contract Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharma Contract Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Contract Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pharma Contract Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharma Contract Service industry.

Chapter 3: Detailed analysis of Pharma Contract Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharma Contract Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharma Contract Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Contract Research Organization (CRO) Table 3. Key Players of Contract Development and Manufacruring Organization (CDMO) Table 4. Key Players of Contract Manufacturing Organization (CMO) Table 4. Global Pharma Contract Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutical Company Table 6. Key Players of Biotechnology Company Table 7. Key Players of Generic Company Table 8. Global Pharma Contract Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Pharma Contract Service Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Pharma Contract Service Market Share by Region (2021-2026) Table 11. Global Pharma Contract Service Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Pharma Contract Service Market Share by Region (2027-2032) Table 13. Pharma Contract Service Industry Trends Table 14. Pharma Contract Service Industry Drivers Table 15. Pharma Contract Service Industry Opportunities and Challenges Table 16. Pharma Contract Service Industry Restraints Table 17. Global Pharma Contract Service Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Pharma Contract Service Revenue Market Share by Company (2021-2026) Table 19. Global Pharma Contract Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Pharma Contract Service Key Company Head Office and Area Served Table 21. Global Pharma Contract Service Company, Product Type & Application Table 22. Global Pharma Contract Service Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Pharma Contract Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Pharma Contract Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharma Contract Service Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Pharma Contract Service Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Pharma Contract Service Revenue Market Share by Type (2021-2026) Table 29. Global Pharma Contract Service Revenue Market Share by Type (2027-2032) Table 30. Global Pharma Contract Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pharma Contract Service Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Pharma Contract Service Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Pharma Contract Service Revenue Market Share by Application (2021-2026) Table 34. Global Pharma Contract Service Revenue Market Share by Application (2027-2032) Table 35. ICON PLC Company Information Table 36. ICON PLC Business Overview Table 37. ICON PLC Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. ICON PLC Pharma Contract Service Product Portfolio Table 39. ICON PLC Recent Development Table 40. IQVIA Company Information Table 41. IQVIA Business Overview Table 42. IQVIA Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. IQVIA Pharma Contract Service Product Portfolio Table 44. IQVIA Recent Development Table 45. PPD Company Information Table 46. PPD Business Overview Table 47. PPD Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. PPD Pharma Contract Service Product Portfolio Table 49. PPD Recent Development Table 50. Eurofins Scientific Company Information Table 51. Eurofins Scientific Business Overview Table 52. Eurofins Scientific Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Eurofins Scientific Pharma Contract Service Product Portfolio Table 54. Eurofins Scientific Recent Development Table 55. WuXi AppTec Company Information Table 56. WuXi AppTec Business Overview Table 57. WuXi AppTec Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. WuXi AppTec Pharma Contract Service Product Portfolio Table 59. WuXi AppTec Recent Development Table 60. Labcorp Drug Development Company Information Table 61. Labcorp Drug Development Business Overview Table 62. Labcorp Drug Development Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Labcorp Drug Development Pharma Contract Service Product Portfolio Table 64. Labcorp Drug Development Recent Development Table 65. Syneos Health Company Information Table 66. Syneos Health Business Overview Table 67. Syneos Health Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Syneos Health Pharma Contract Service Product Portfolio Table 69. Syneos Health Recent Development Table 70. Parexel Company Information Table 71. Parexel Business Overview Table 72. Parexel Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Parexel Pharma Contract Service Product Portfolio Table 74. Parexel Recent Development Table 75. Medpace Company Information Table 76. Medpace Business Overview Table 77. Medpace Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Medpace Pharma Contract Service Product Portfolio Table 79. Medpace Recent Development Table 80. Charles River Company Information Table 81. Charles River Business Overview Table 82. Charles River Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Charles River Pharma Contract Service Product Portfolio Table 84. Charles River Recent Development Table 85. Lonza Company Information Table 86. Lonza Business Overview Table 87. Lonza Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Lonza Pharma Contract Service Product Portfolio Table 89. Lonza Recent Development Table 90. Aldevron Company Information Table 91. Aldevron Business Overview Table 92. Aldevron Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Aldevron Pharma Contract Service Product Portfolio Table 94. Aldevron Recent Development Table 95. Catalent Company Information Table 96. Catalent Business Overview Table 97. Catalent Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Catalent Pharma Contract Service Product Portfolio Table 99. Catalent Recent Development Table 100. North America Pharma Contract Service Market Size by Type (2021-2026) & (US$ Million) Table 101. North America Pharma Contract Service Market Size by Type (2027-2032) & (US$ Million) Table 102. North America Pharma Contract Service Market Size by Application (2021-2026) & (US$ Million) Table 103. North America Pharma Contract Service Market Size by Application (2027-2032) & (US$ Million) Table 104. North America Pharma Contract Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Pharma Contract Service Market Size by Country (2021-2026) Table 106. North America Pharma Contract Service Market Size by Country (2027-2032) Table 107. Europe Pharma Contract Service Market Size by Type (2021-2026) & (US$ Million) Table 108. Europe Pharma Contract Service Market Size by Type (2027-2032) & (US$ Million) Table 109. Europe Pharma Contract Service Market Size by Application (2021-2026) & (US$ Million) Table 110. Europe Pharma Contract Service Market Size by Application (2027-2032) & (US$ Million) Table 111. Europe Pharma Contract Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Pharma Contract Service Market Size by Country (2021-2026) Table 113. Europe Pharma Contract Service Market Size by Country (2027-2032) Table 114. China Pharma Contract Service Market Size by Type (2021-2026) & (US$ Million) Table 115. China Pharma Contract Service Market Size by Type (2027-2032) & (US$ Million) Table 116. China Pharma Contract Service Market Size by Application (2021-2026) & (US$ Million) Table 117. China Pharma Contract Service Market Size by Application (2027-2032) & (US$ Million) Table 118. Asia Pharma Contract Service Market Size by Type (2021-2026) & (US$ Million) Table 119. Asia Pharma Contract Service Market Size by Type (2027-2032) & (US$ Million) Table 120. Asia Pharma Contract Service Market Size by Application (2021-2026) & (US$ Million) Table 121. Asia Pharma Contract Service Market Size by Application (2027-2032) & (US$ Million) Table 122. Asia Pharma Contract Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Asia Pharma Contract Service Market Size by Country (2021-2026) Table 124. Asia Pharma Contract Service Market Size by Country (2027-2032) Table 125. South America, Middle East & Africa Pharma Contract Service Market Size by Type (2021-2026) & (US$ Million) Table 126. South America, Middle East & Africa Pharma Contract Service Market Size by Type (2027-2032) & (US$ Million) Table 127. South America, Middle East & Africa Pharma Contract Service Market Size by Application (2021-2026) & (US$ Million) Table 128. South America, Middle East & Africa Pharma Contract Service Market Size by Application (2027-2032) & (US$ Million) Table 129. South America, Middle East & Africa Pharma Contract Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. South America, Middle East & Africa Pharma Contract Service Market Size by Country (2021-2026) Table 131. South America, Middle East & Africa Pharma Contract Service Market Size by Country (2027-2032) Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Pharma Contract Service Product Image Figure 2. Global Pharma Contract Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pharma Contract Service Market Share by Type: 2025 VS 2032 Figure 4. Contract Research Organization (CRO) Image Figure 5. Contract Development and Manufacruring Organization (CDMO) Image Figure 6. Contract Manufacturing Organization (CMO) Image Figure 7. Global Pharma Contract Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Pharma Contract Service Market Share by Application: 2025 VS 2032 Figure 9. Pharmaceutical Company Image Figure 10. Biotechnology Company Image Figure 11. Generic Company Image Figure 12. Global Pharma Contract Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 14. Global Pharma Contract Service Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Pharma Contract Service Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Pharma Contract Service Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Pharma Contract Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pharma Contract Service Revenue Market Share by Type (2021-2032) Figure 21. Global Pharma Contract Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Pharma Contract Service Revenue Market Share by Application (2021-2032) Figure 23. North America Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 24. North America Pharma Contract Service Market Share by Type (2021-2032) Figure 25. North America Pharma Contract Service Market Share by Application (2021-2032) Figure 26. North America Pharma Contract Service Market Share by Country (2021-2032) Figure 27. United States Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 28. Canada Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 30. Europe Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 31. Europe Pharma Contract Service Market Share by Type (2021-2032) Figure 32. Europe Pharma Contract Service Market Share by Application (2021-2032) Figure 33. Europe Pharma Contract Service Market Share by Country (2021-2032) Figure 34. Germany Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 35. France Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 37. Italy Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 38. Russia Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 40. China Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 41. China Pharma Contract Service Market Share by Type (2021-2032) Figure 42. China Pharma Contract Service Market Share by Application (2021-2032) Figure 43. Asia Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 44. Asia Pharma Contract Service Market Share by Type (2021-2032) Figure 45. Asia Pharma Contract Service Market Share by Application (2021-2032) Figure 46. Asia Pharma Contract Service Market Share by Country (2021-2032) Figure 47. Japan Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 51. India Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 52. Australia Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Pharma Contract Service Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Pharma Contract Service Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Pharma Contract Service Market Share by Country (2021-2032) Figure 57. Brazil Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 62. UAE Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 64. Chile Pharma Contract Service Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Contract Research Organization (CRO)
  • Contract Development and Manufacruring Organization (CDMO)
  • Contract Manufacturing Organization (CMO)
Applications
  • Pharmaceutical Company
  • Biotechnology Company
  • Generic Company
Companies covered
  • ICON PLC
  • IQVIA
  • PPD
  • Eurofins Scientific
  • WuXi AppTec
  • Labcorp Drug Development
  • Syneos Health
  • Parexel
  • Medpace
  • Charles River
  • Lonza
  • Aldevron
  • Catalent

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pharma Contract Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Contract Research Organization (CRO)
  5. 1.2.3 Contract Development and Manufacruring Organization (CDMO)
  6. 1.2.4 Contract Manufacturing Organization (CMO)
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Pharma Contract Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmaceutical Company
  10. 1.3.3 Biotechnology Company
  11. 1.3.4 Generic Company
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Pharma Contract Service Growth Trends by Region
  14. 1.5.1 Global Pharma Contract Service Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Pharma Contract Service Market Size by Region (2021-2026)
  16. 1.5.3 Pharma Contract Service Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Pharma Contract Service Market Dynamics
  1. 2.1 Pharma Contract Service Industry Trends
  2. 2.2 Pharma Contract Service Industry Drivers
  3. 2.3 Pharma Contract Service Industry Opportunities and Challenges
  4. 2.4 Pharma Contract Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pharma Contract Service Revenue by Company (2021-2026)
  2. 3.2 Global Pharma Contract Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pharma Contract Service Key Company Head office and Area Served
  4. 3.4 Global Pharma Contract Service Company, Product Type & Application
  5. 3.5 Global Pharma Contract Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pharma Contract Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pharma Contract Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pharma Contract Service Tier 1, Tier 2, and Tier 3
4 Pharma Contract Service Market by Type
  1. 4.1 Global Pharma Contract Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pharma Contract Service Market Size by Type (2021-2032)
  3. 4.3 Global Pharma Contract Service Market Size Share by Type (2021-2032)
5 Pharma Contract Service Market by Application
  1. 5.1 Global Pharma Contract Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharma Contract Service Market Size by Application (2021-2032)
  3. 5.3 Global Pharma Contract Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 ICON PLC
  2. 6.1.1 ICON PLC Company Information
  3. 6.1.2 ICON PLC Business Overview
  4. 6.1.3 ICON PLC Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 ICON PLC Pharma Contract Service Product Portfolio
  6. 6.1.5 ICON PLC Recent Developments
  7. 6.2 IQVIA
  8. 6.2.1 IQVIA Company Information
  9. 6.2.2 IQVIA Business Overview
  10. 6.2.3 IQVIA Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 IQVIA Pharma Contract Service Product Portfolio
  12. 6.2.5 IQVIA Recent Developments
  13. 6.3 PPD
  14. 6.3.1 PPD Company Information
  15. 6.3.2 PPD Business Overview
  16. 6.3.3 PPD Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 PPD Pharma Contract Service Product Portfolio
  18. 6.3.5 PPD Recent Developments
  19. 6.4 Eurofins Scientific
  20. 6.4.1 Eurofins Scientific Company Information
  21. 6.4.2 Eurofins Scientific Business Overview
  22. 6.4.3 Eurofins Scientific Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Eurofins Scientific Pharma Contract Service Product Portfolio
  24. 6.4.5 Eurofins Scientific Recent Developments
  25. 6.5 WuXi AppTec
  26. 6.5.1 WuXi AppTec Company Information
  27. 6.5.2 WuXi AppTec Business Overview
  28. 6.5.3 WuXi AppTec Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 WuXi AppTec Pharma Contract Service Product Portfolio
  30. 6.5.5 WuXi AppTec Recent Developments
  31. 6.6 Labcorp Drug Development
  32. 6.6.1 Labcorp Drug Development Company Information
  33. 6.6.2 Labcorp Drug Development Business Overview
  34. 6.6.3 Labcorp Drug Development Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Labcorp Drug Development Pharma Contract Service Product Portfolio
  36. 6.6.5 Labcorp Drug Development Recent Developments
  37. 6.7 Syneos Health
  38. 6.7.1 Syneos Health Company Information
  39. 6.7.2 Syneos Health Business Overview
  40. 6.7.3 Syneos Health Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Syneos Health Pharma Contract Service Product Portfolio
  42. 6.7.5 Syneos Health Recent Developments
  43. 6.8 Parexel
  44. 6.8.1 Parexel Company Information
  45. 6.8.2 Parexel Business Overview
  46. 6.8.3 Parexel Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Parexel Pharma Contract Service Product Portfolio
  48. 6.8.5 Parexel Recent Developments
  49. 6.9 Medpace
  50. 6.9.1 Medpace Company Information
  51. 6.9.2 Medpace Business Overview
  52. 6.9.3 Medpace Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Medpace Pharma Contract Service Product Portfolio
  54. 6.9.5 Medpace Recent Developments
  55. 6.10 Charles River
  56. 6.10.1 Charles River Company Information
  57. 6.10.2 Charles River Business Overview
  58. 6.10.3 Charles River Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Charles River Pharma Contract Service Product Portfolio
  60. 6.10.5 Charles River Recent Developments
  61. 6.11 Lonza
  62. 6.11.1 Lonza Company Information
  63. 6.11.2 Lonza Business Overview
  64. 6.11.3 Lonza Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Lonza Pharma Contract Service Product Portfolio
  66. 6.11.5 Lonza Recent Developments
  67. 6.12 Aldevron
  68. 6.12.1 Aldevron Company Information
  69. 6.12.2 Aldevron Business Overview
  70. 6.12.3 Aldevron Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Aldevron Pharma Contract Service Product Portfolio
  72. 6.12.5 Aldevron Recent Developments
  73. 6.13 Catalent
  74. 6.13.1 Catalent Company Information
  75. 6.13.2 Catalent Business Overview
  76. 6.13.3 Catalent Pharma Contract Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Catalent Pharma Contract Service Product Portfolio
  78. 6.13.5 Catalent Recent Developments
7 North America
  1. 7.1 North America Pharma Contract Service Market Size (2021-2032)
  2. 7.2 North America Pharma Contract Service Market Size by Type
  3. 7.2.1 North America Pharma Contract Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Pharma Contract Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Pharma Contract Service Market Share by Type (2021-2032)
  6. 7.3 North America Pharma Contract Service Market Size by Application
  7. 7.3.1 North America Pharma Contract Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Pharma Contract Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Pharma Contract Service Market Share by Application (2021-2032)
  10. 7.4 North America Pharma Contract Service Market Size by Country
  11. 7.4.1 North America Pharma Contract Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pharma Contract Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Pharma Contract Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Pharma Contract Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pharma Contract Service Market Size (2021-2032)
  2. 8.2 Europe Pharma Contract Service Market Size by Type
  3. 8.2.1 Europe Pharma Contract Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pharma Contract Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pharma Contract Service Market Share by Type (2021-2032)
  6. 8.3 Europe Pharma Contract Service Market Size by Application
  7. 8.3.1 Europe Pharma Contract Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pharma Contract Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pharma Contract Service Market Share by Application (2021-2032)
  10. 8.4 Europe Pharma Contract Service Market Size by Country
  11. 8.4.1 Europe Pharma Contract Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pharma Contract Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pharma Contract Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pharma Contract Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pharma Contract Service Market Size (2021-2032)
  2. 9.2 China Pharma Contract Service Market Size by Type
  3. 9.2.1 China Pharma Contract Service Market Size by Type (2021-2026)
  4. 9.2.2 China Pharma Contract Service Market Size by Type (2027-2032)
  5. 9.2.3 China Pharma Contract Service Market Share by Type (2021-2032)
  6. 9.3 China Pharma Contract Service Market Size by Application
  7. 9.3.1 China Pharma Contract Service Market Size by Application (2021-2026)
  8. 9.3.2 China Pharma Contract Service Market Size by Application (2027-2032)
  9. 9.3.3 China Pharma Contract Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pharma Contract Service Market Size (2021-2032)
  2. 10.2 Asia Pharma Contract Service Market Size by Type
  3. 10.2.1 Asia Pharma Contract Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pharma Contract Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pharma Contract Service Market Share by Type (2021-2032)
  6. 10.3 Asia Pharma Contract Service Market Size by Application
  7. 10.3.1 Asia Pharma Contract Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pharma Contract Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pharma Contract Service Market Share by Application (2021-2032)
  10. 10.4 Asia Pharma Contract Service Market Size by Country
  11. 10.4.1 Asia Pharma Contract Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pharma Contract Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pharma Contract Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pharma Contract Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pharma Contract Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pharma Contract Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pharma Contract Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pharma Contract Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pharma Contract Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pharma Contract Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pharma Contract Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pharma Contract Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pharma Contract Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pharma Contract Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pharma Contract Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pharma Contract Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pharma Contract Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pharma Contract Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst